| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |